A new obesity tackling drug is twice as effective as current over-the-counter diet drugs a new study from Duke University, North Carolina has revealed.
As well as offering a valuable treatment for obesity, the new drug, which combines two existing drugs, provides further health benefits such as improving blood pressure and reducing cholesterol levels.
The study found that the new drug, Qnexa, achieved up to 10% weight loss, which is more than double that of Orlistat the anti-obesity drug currently available on the NHS.
The new drug works by reducing hunger and making you feel fuller for longer. The drug which is a combination of the drugs phentermine and topiramate was tested on 2,500 overweight US adults. Testing involved some of
No comments:
Post a Comment